These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18607669)

  • 1. Design of the POSSIBLE UStrade mark Study: postmenopausal women's compliance and persistence with osteoporosis medications.
    Barrett-Connor E; Ensrud K; Tosteson AN; Varon SF; Anthony M; Daizadeh N; Wade S
    Osteoporos Int; 2009 Mar; 20(3):463-72. PubMed ID: 18607669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.
    Lukert B; Satram-Hoang S; Wade S; Anthony M; Gao G; Downs R
    Drugs Aging; 2011 Sep; 28(9):713-27. PubMed ID: 21913737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy.
    Wade SW; Satram-Hoang S; Nadkar A; Macarios D; Tosteson AN
    Clin Ther; 2011 Dec; 33(12):2006-15. PubMed ID: 22099387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™.
    Barrett-Connor E; Wade SW; Do TP; Satram-Hoang S; Stewart R; Gao G; Macarios D
    Osteoporos Int; 2012 Feb; 23(2):733-41. PubMed ID: 21625886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™.
    Wade SW; Satram-Hoang S; Stolshek BS
    Osteoporos Int; 2014 Sep; 25(9):2279-90. PubMed ID: 24942502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™.
    Barrett-Connor E; Wade SW; Downs RW; Ganiats T; Hochberg M; Recker RR; Stolshek BS
    Osteoporos Int; 2015 Aug; 26(8):2175-84. PubMed ID: 25876880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Hadji P; Papaioannou N; Gielen E; Feudjo Tepie M; Zhang E; Frieling I; Geusens P; Makras P; Resch H; Möller G; Kalouche-Khalil L; Fahrleitner-Pammer A
    Osteoporos Int; 2015 Oct; 26(10):2479-89. PubMed ID: 26018090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study.
    Silverman SL; Siris E; Belazi D; Recknor C; Papaioannou A; Brown JP; Gold DT; Lewiecki EM; Quinn G; Balasubramanian A; Yue S; Stolshek B; Kendler DL
    Arch Osteoporos; 2018 Aug; 13(1):85. PubMed ID: 30088189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication persistence in older women with osteoporosis: a pilot study.
    Gillette C; Howerton DM; Williams BD; Mahmood MA
    Osteoporos Int; 2015 Dec; 26(12):2883-8. PubMed ID: 26194492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study.
    Senay A; Fernandes JC; Delisle J; Morin SN; Perreault S
    Arch Osteoporos; 2019 Aug; 14(1):87. PubMed ID: 31375983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of adherence to osteoporosis treatment in clinical practice.
    Rossini M; Bianchi G; Di Munno O; Giannini S; Minisola S; Sinigaglia L; Adami S;
    Osteoporos Int; 2006; 17(6):914-21. PubMed ID: 16538553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study.
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown P; Sajjan S
    Osteoporos Int; 2018 Feb; 29(2):329-337. PubMed ID: 29110061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to do about postmenopausal fracture risk. Diet, exercise, calcium, and vitamin D are always important, but women at high risk for fractures may need drug therapy, too.
    Harv Womens Health Watch; 2009 Dec; 17(4):1-3. PubMed ID: 20088086
    [No Abstract]   [Full Text] [Related]  

  • 16. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium and vitamin D intake by postmenopausal women with osteoporosis in France.
    Czernichow S; Fan T; Nocea G; Sen SS
    Curr Med Res Opin; 2010 Jul; 26(7):1667-74. PubMed ID: 20446889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
    Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H
    Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of therapeutic compliance in women with osteoporosis].
    Carbonell Abella C; Guañabens Gay N; Regadera Anechina L; Marín Rives JA; Taverna Llauradó E; Ayechu Redín MP;
    Reumatol Clin; 2011; 7(5):299-304. PubMed ID: 21925445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to anti-osteoporotic therapies: role and determinants of "spot therapy".
    Tafaro L; Nati G; Leoni E; Baldini R; Cattaruzza MS; Mei M; Falaschi P
    Osteoporos Int; 2013 Aug; 24(8):2319-23. PubMed ID: 23404614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.